Page last updated: 2024-08-24

3-iodobenzylguanidine and Angiomyolipoma

3-iodobenzylguanidine has been researched along with Angiomyolipoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hayashi, M; Iha, T; Kouki, T; Ogawa, Y; Ohshiro, Y; Takara, M; Takasu, N	1

Other Studies

1 other study(ies) available for 3-iodobenzylguanidine and Angiomyolipoma

Article	Year
False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma. Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:20 Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Angiomyolipoma; Diagnosis, Differential; False Positive Reactions; Female; Humans; Magnetic Resonance Angiography; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2007

Article

Year

False-positive 123I-metaiodobenzylguanidine (MIBG) scan in a patient with angiomyolipoma; positive MIBG scan does not necessarily indicate the presence of pheochromocytoma.

Internal medicine (Tokyo, Japan), 2007, Volume: 46, Issue:20

Topics: 3-Iodobenzylguanidine; Adrenal Gland Neoplasms; Adult; Angiomyolipoma; Diagnosis, Differential; False Positive Reactions; Female; Humans; Magnetic Resonance Angiography; Pheochromocytoma; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon

2007